Log In
BCIQ
Print this Print this
 

Proprotein convertase subtilisin/kexin type 9 (PCSK9)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Proprotein convertase subtilisin/kexin type 9 (PCSK9)

BCIQ
Print ChartPrint this
2 3 2 1 1 1 1 0 1 0 0 0
Phases of DevelopmentPreclinicalPhase IPhase IIPhase IIIApprovedMarketed
Cardiovascular

1

0

1

0

0

0

Endocrine / Metabolic

2

3

2

1

1

1




 Products Targeting Proprotein convertase subtilisin/kexin type 9 (PCSK9)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

4

$205.0M

$25.0M

$180.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today